Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Non-Hodgkin's Lymphoma treatment details. Chemotherapy. UPMC Université Paris, Paris, France



Survival: 69.8 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs:
Country: France
   
City/State/Province: Paris
   
Hospital: UPMC Université Paris
   
Journal: Link
   
Date: 1/2013

Description:
Patients:
This study involved 207 patients with untreated Waldenstrom macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma. The median patient age was 67.8 years and 67% were male.

Treatment:
Patients were treated with the chemotherapy agent called chlorambucil.

Toxicities:
Four treatment-related deaths due to infection were reported. Grade 4 neutropenia, liver enzyme abnormalities, and lung toxicity were also reported.

Results:
The median overall survival was 69.8 months.

Support:
This study was supported by Schering and Bayer Pharmaceuticals.

Correspondence: Dr. Veronique Leblond; email: Veronique.leblond@psl.aphp.fr

E-mail to a Friend Email Physician More Information